Onderzoeker
Tom Decroo
Affiliaties
- Hiv en Tuberculose (Onderzoekseenheid)
Lid
Vanaf1 okt 2021 → Heden - Seksuele Gezondheid inclusief Hiv (Onderzoekseenheid)
Lid
Vanaf13 okt 2015 → 29 jun 2017 - Hiv en Tuberculose (Onderzoekseenheid)
Lid
Vanaf1 jul 2013 → 30 sep 2021
Projecten
1 - 10 of 13
- Drug resistant tuberculosis: optimize the composition of new treatment regimens in VietnamVanaf1 jan 2023 → Heden
- Impact of diagnostic delays and short treatment regimens on outcomes of rifampicin-resistant tuberculosis patients in CameroonVanaf1 jan 2022 → Heden
- TB/NTM OnderzoeksclusterVanaf1 jan 2022 → Heden
- Nontuberculous mycobacteria pulmonary disease and tuberculosis-nontuberculous mycobacteria co-infection: Epidemiology, diagnosis, and management at a tertiary health facility in GhanaVanaf1 jan 2022 → Heden
- Alternative methodological approaches to assess longterm HIV virological and clinical outcomes in resource limited settingsVanaf27 apr 2021 → Heden
- Performance of community-based ART programmes for key populations in Nigeria and sub-Saharan AfricaVanaf1 jan 2021 → Heden
- Accurate diagnosis and effective treatment for tuberculosis retreatment patients in NigerVanaf1 jan 2021 → Heden
- Innovative diagnostic and therapeutic measures to improve MDR-TB diagnosis and management in Conakry, GuineaVanaf1 jan 2020 → Heden
- Novel High-Dose Tuberculosis Retreatment Regimens: How to overcome resistance without Creating MoreVanaf1 okt 2018 → Heden
- Novel high-dose tuberclosis retreatment regimens: How to overcome resistance without creating more?Vanaf1 okt 2018 → 30 sep 2021
Publicaties
51 - 60 van 127
- Comparison of first-line tuberculosis treatment outcomes between previously treated and new patients: a retrospective study in Machakos subcounty, Kenya(2021)
Auteurs: Johannes Ndambuki, Joseph Nzomo, Lucy Muregi, Chris Mutuku, Francis Makokha, Jonathan Nthusi, Clarice Ambale, L Lynen, Tom Decroo
Pagina's: 272-280 - Case report: therapeutic threshold for rifampicin-resistant tuberculosis: a case report from Maputo, Mozambique(2021)
Auteurs: Lorena D M Gonzaga, Tinne Gils, Tom Decroo, Bart K Jacobs, Lutgarde Lynen
Pagina's: 1317-1320 - How to bring residents' psychosocial well-being to the heart of the fight against Covid-19 in Belgian nursing homes; a qualitative study(2021)
Auteurs: Sanne Kaelen, Wilma van den Boogaard, Umberto Pellecchia, Sofie Spiers, Caroline De Cramer, Gwennin Demaegd, Edouard Fouqueray, Rafael Van den Bergh, Stephanie Goublomme, Tom Decroo, et al.
- Predictors of virological failure among people living with HIV receiving first line antiretroviral treatment in Myanmar: retrospective cohort analysis(2021)
Auteurs: Anita Mesic, Alexander Spina, Htay Thet Mar, Phone Thit, Tom Decroo, Annick Lenglet, Moe Pyae Thandar, Thin Thin Thwe, Aung Aung Kyaw, Tobias Homan, et al.
- Rifampicin-resistant tuberculosis treatment: way forward without hampering future options?(2021)
Auteurs: Tom Decroo, Anita Mesic, Bouke de Jong, L Rigouts, Tinne Gils, J. Mallick, Lutgarde Lynen
Pagina's: 255-255 - Bedaquiline can act as core drug in a standardized treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis(2021)
Auteurs: Tom Decroo, Kya Jai, Kya Jai Maug Aung, Mohamed Anwar Hossain, M Gumusboga, Nimer Ortuno-Gutierrez, Bouke de Jong, Armand Van Deun
- High-dose first-line treatment regimen for recurrent rifampicin-susceptible tuberculosis(2020)
Auteurs: Tom Decroo, Bouke de Jong, Alberto Piubello, Mahamadou Bassirou Souleymane, Lutgarde Lynen, A Van Deun
Pagina's: 1578-1579 - Injectables' key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes(2020)
Auteurs: Tom Decroo, Aung Kya Jai Maug, Mohamed Anwar Hossain, C Uwizeye, M Gumusboga, Tine Demeulenaere, Nimer Ortuno-Gutierrez, Bouke de Jong, Armand Van Deun
- First-line tuberculosis treatment with double-dose rifampicin is well tolerated(2020)
Auteurs: A.K.J. Maug, M.A. Hossain, M Gumusboga, Tom Decroo, W Mulders, Sofie Braet, Jozefien Buyze, Diana Arango, Céline Schurmans, Natacha Herssens, et al.
Pagina's: 499-505 - Better programmatic outcome with the shorter regimen for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Guinea: a retrospective cohort stud(2020)
Auteurs: Souleymane Hassane-Harouna, Gba-Foromo Cherif, Nimer Ortuno-Gutierrez, Diao Cisse, Lansana Mady Camara, Boubacar Djelo Diallo, Souleymane Camara, Adama Marie Bangoura, Lut Lynen, Tom Decroo